President and CEO of Angiotech Pharmaceuticals Inc. (ANPI, Financial) William L Hunter buys 49,500 shares of ANPI on 09/29/2009 at an average price of $1.9 a share.
Angiotech Pharmaceuticals Inc. is a Canadian pharmaceutical company dedicated to the development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug paclitaxel. These treatments are based upon the company's discovery that paclitaxel blocks an important cellular pathway involved in inflammation. The company's goal is to establish a leadership position in the development of treatments for chronic inflammatory diseases. Angiotech Pharmaceuticals Inc. has a market cap of $146.6 million; its shares were traded at around $1.76 with and P/S ratio of 0.5.
Recent Trades of Angiotech Pharmaceuticals Inc. by CEO:
Recent Trades of Angiotech Pharmaceuticals Inc. by CFO:
Recent Trades of Angiotech Pharmaceuticals Inc. by Directors and Officers:
Angiotech Pharmaceuticals Inc. is a Canadian pharmaceutical company dedicated to the development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug paclitaxel. These treatments are based upon the company's discovery that paclitaxel blocks an important cellular pathway involved in inflammation. The company's goal is to establish a leadership position in the development of treatments for chronic inflammatory diseases. Angiotech Pharmaceuticals Inc. has a market cap of $146.6 million; its shares were traded at around $1.76 with and P/S ratio of 0.5.
Recent Trades of Angiotech Pharmaceuticals Inc. by CEO:
- Buy: President & CEO William L Hunter bought 157,738 shares of ANPI stock on 05/05/2009 at the average price of $0.55; the price of the stock has increased by 220% since.
- Buy: President & CEO William L Hunter bought 476,813 more shares of ANPI stock on 05/04/2009 at the average price of $0.55; the price of the stock has increased by 220% since.
Recent Trades of Angiotech Pharmaceuticals Inc. by CFO:
- Buy: CFO K Thomas Bailey bought 30,000 shares of ANPI stock on 08/18/2009 at the average price of $1.67; the price of the stock has increased by 5.39% since.
Recent Trades of Angiotech Pharmaceuticals Inc. by Directors and Officers:
- Buy: SVP, Research & Development Jeffrey M Gross bought 6,000 shares of ANPI stock on 08/27/2009 at the average price of $1.68; the price of the stock has increased by 4.76% since.
- Buy: SVP, Research & Development Jeffrey M Gross bought 6,000 more shares of ANPI stock on 08/27/2009 at the average price of $1.68; the price of the stock has increased by 4.76% since.
- Buy: SVP, Research & Development Jeffrey M Gross bought 3,500 more shares of ANPI stock on 08/14/2009 at the average price of $1.77; the price of the stock has decreased by 0.56% since.
- Buy: SVP, Human Resources Tammy Neske bought 6,300 shares of ANPI stock on 08/14/2009 at the average price of $1.9; the price of the stock has decreased by 7.37% since.
- Buy: SVP, Finance Jay Bernard Dent bought 16,700 shares of ANPI stock on 08/13/2009 at the average price of $1.95; the price of the stock has decreased by 9.74% since.
